Announced details
Targeted skincare for the visible appearance of fine lines caused by dryness and a lack of firmness around the eyes, mouth, forehead and nasolabial folds
Hyaluronic acid content doubled compared with the previous product
More than 800,000 units sold cumulatively since launch (previous product, as of the announcement date)
Sold as a product under the company’s own brand
¥6,596 (including tax)
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | CONC Wrinkle Injection Gen2, CONC Wrinkle Injection |
| Relationship with the Company | Sold as a product under the company’s own brand |
| Offering price | ¥6,596 (including tax) |
| Launch date | 1 September 2026 (planned) |
| Applicable area | Targeted skincare for the visible appearance of fine lines caused by dryness and a lack of firmness around the eyes, mouth, forehead and nasolabial folds |
| Quantitative Effects | Hyaluronic acid content doubled compared with the previous product |
| Usage history | More than 800,000 units sold cumulatively since launch (previous product, as of the announcement date) |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To advance the formulation based on the first-generation product’s sales performance and customer feedback, thereby improving the lasting moisturizing and firming effects.